Twin Bridge Invests in Alcanza Clinical Research
![](https://twinbridgecapital.com/wp-content/uploads/2022/10/Capture.jpg)
![](https://twinbridgecapital.com/wp-content/uploads/2021/04/HeaderImage_Home_NotDarkened_1-scaled.jpg?auto=format,compress&q=80)
Washington, DC, October 03, 2022, ̶ To stay ahead of the urgent needs of equitable healthcare, Martis Capital, a leading middle market healthcare fund, is excited to announce its investment in Alcanza Clinical Research. Founded in December 2021 and named for the Spanish word “reach,” Alcanza is a clinical research site network platform dedicated to creating a sustainable and inclusive clinical trial environment for all.
To read more about the investment, please visit here